Hailie inhaler monitoring system maker Adherium has announced the appointment of Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs. Creaven-Capasso has been a long-time regulatory affairs consultant; earlier in her career, she also held QA positions at several companies, including Xoma and Medtronic. Adherium received 510(k) clearance for its next … [Read more...] about Adherium names Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs
People
Proveris names Ramesh Chand as Associate Director of Proveris Laboratories
Proveris Scientific has named Ramesh Chand as Associate Director of Proveris Laboratories, the company's contract testing business, which launched in May 2020. Chand was most recently Principal Scientist in Respiratory Drug Product Development at Moderna and previously held positions in OINDP research at GSK, Lovelace Biomedical, and Amneal … [Read more...] about Proveris names Ramesh Chand as Associate Director of Proveris Laboratories
Adherium announces the appointment of Francis White as VP of Global Business Development
Inhaler monitoring company Adherium has announced the appointment of Francis White as VP of Global Business Development. White was most recently Managing Director of Olympus Medical in the UK and Ireland and previously held business development roles at AliveCor and Medtronic. Adherium's next generation Hailie inhaler sensor platform received 501(k) clearance in … [Read more...] about Adherium announces the appointment of Francis White as VP of Global Business Development
Pulmatrix hires Margaret Wasilewski as Chief Medical Officer
DPI developer Pulmatrix has hired Margaret Wasilewski as its Chief Medical Officer, the company said. Wasilewski most recently offered consulting services as President of ID Remedies, and her previous experience includes clinical development positions at Shire, Tetraphase Pharmaceuticals, Targanta Therapeutics, and Eli Lilly. Pulmatrix's pipeline includes … [Read more...] about Pulmatrix hires Margaret Wasilewski as Chief Medical Officer
Thomas G. O’Riordan named Editor-in-Chief of the Journal of Aerosol Medicine and Pulmonary Drug Delivery
The Journal of Aerosol Medicine and Pulmonary Drug Delivery, the official journal of the International Society for Aerosols in Medicine (ISAM), has announced that GSK VP US Medical and Therapy Head for Respiratory Thomas G. O’Riordan will take over as Editor-in-Chief as of March 1, 2022. His predecessor, Gerry Smaldone, announced in October 2021 that he would step … [Read more...] about Thomas G. O’Riordan named Editor-in-Chief of the Journal of Aerosol Medicine and Pulmonary Drug Delivery
Gilbert Technologies names Scott Fleming Chief Commercial Officer
Gilbert Technologies, which is developing a soft mist inhaler device based on electrohydrodynamic atomization technology, announced that Scott Fleming will take on the role of Chief Commercial Officer. Fleming, who has been the company's Technology Director for the past two years, has extensive experience in OINDPs. A co-founder of inhaled drug developer Microdose … [Read more...] about Gilbert Technologies names Scott Fleming Chief Commercial Officer
Jean-Luc Herbeaux to succeed Guy Villax as Hovione CEO
CDMO Hovione has announced that Jean-Luc Herbeaux will succeed Guy Villax as CEO of Hovione as of April 1, 2022. Herbeaux joined Hovione as Chief Operating Officer in 2020 after having served in various executive roles at Evonik. Villax will remain a member of the company's board of directors. According to the announcement, the company, which offers inhalation … [Read more...] about Jean-Luc Herbeaux to succeed Guy Villax as Hovione CEO
Ethris raises $26.3 million for development of inhaled mRNA therapies
Ethris GmbH said that it has closed a $26.3 million Series B financing round led by Laureus Capital, with proceeds earmarked for continued development of the company's ETH47 and ETH42 inhaled mRNA based therapies, which are currently in preclinical development. The company also said that Laureus Capital founder and CEO Christian Wawrzinek will become Managing … [Read more...] about Ethris raises $26.3 million for development of inhaled mRNA therapies
IPAC-RS announces board changes
The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) has announced that Kindeva Drug Delivery Global Respiratory Product Development Manager Mike Needham will serve as Vice Chair of the IPAC-RS board until June 1, 2022 and will then take over as Chair, succeeding Carla Vozone of Catalent Pharma Solutions who will become Chair … [Read more...] about IPAC-RS announces board changes
ReCode Therapeutics names Shehnaaz Suliman as CEO
ReCode Therapeutics, which recently raised $80 million for development of inhaled genetic therapies for cystic fibrosis and primary ciliary dyskinesia (PCD), has announced the appointment of former Theravance Biopharma executive Shehnaaz Suliman as CEO and a member of the company's board of directors. She succeeds David Lockhart as CEO; Lockhart will continue as … [Read more...] about ReCode Therapeutics names Shehnaaz Suliman as CEO